• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

HeartSciences Inc. - Warrant (NQ:HSCSW)

0.0602 UNCHANGED
Last Price Updated: 2:52 PM EDT, Oct 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0602
Bid (Size) 0.0460 (5,900)
Ask (Size) 0.0800 (200)
Prev. Close 0.0602
Today's Range 0.0602 - 0.0602
52wk Range 0.0350 - 0.1439
Shares Outstanding 10,362,284
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
HeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining
Today 8:30 EDT
Shareholder Special Meeting Scheduled for November 19, 2026 
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM Device
October 06, 2026
From HeartSciences Inc.
Via GlobeNewswire

Performance

52-Week Range 58.2% below 52-week high
0.0602
0.0452W Low 0.1452W High

HeartSciences Inc. - Warrant (HSCSW) traded between $0.04 and $0.14 over the past 52 weeks and last traded at $0.06, 58.2% below its 52-week high.

Past 12 Months
N/A
+37.8%
+19.2%
-0.5%
-22.3%
-16.9%
1W  
1M +$0.02
3M +$0.01
6M -$0.00
YTD -$0.02
1Y -$0.01

HSCSW was -16.9% over the past year, -0.5% over six months, -22.3% year to date.

12 Months vs Market
HSCSW
-16.9%
DIA
+12.3%
SPY
+14.6%
QQQ
+17.3%
IWM
+11.1%

Over the past 12 months HSCSW returned -16.9% versus DIA (Dow) +12.3%, SPY (S&P 500) +14.6%, QQQ (Nasdaq 100) +17.3% and IWM (Russell 2000) +11.1%.

Volume & Liquidity
1W
6.0
1M
2.3K
3M
5.3K
6M
5.1K
YTD
4.2K
1Y
3.4K

HSCSW's 3-month average daily volume is 5.3K.

More News

Read More
News headline image
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
September 15, 2026
From HeartSciences Inc.
Via GlobeNewswire
News headline image
Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration
August 19, 2026
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results
July 29, 2026
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K
July 23, 2026
From HeartSciences Inc.
Via GlobeNewswire
News headline image
European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences’ Patent Portfolio to More Than 45 Granted Patents
June 11, 2026
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm
June 02, 2026
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network
May 19, 2026
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™
May 05, 2026
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting
April 14, 2026
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category
March 25, 2026
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings
March 24, 2026
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
March 16, 2026
From HeartSciences Inc.
Via GlobeNewswire
News headline image
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
February 05, 2026
From HeartSciences Inc.
Via GlobeNewswire
News headline image
Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals
January 29, 2026
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
December 15, 2025
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device
December 15, 2025
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1
December 11, 2025
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results
September 11, 2025
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Announces Conference Participation and Investor Webinar
August 15, 2025
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results
July 24, 2025
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis
June 04, 2025
From HeartSciences Inc.
Via GlobeNewswire
News headline image
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value
June 03, 2025
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone
May 29, 2025
From HeartSciences Inc.
Via GlobeNewswire

Frequently Asked Questions

Is HeartSciences Inc. - Warrant publicly traded?
Yes, HeartSciences Inc. - Warrant is publicly traded.
What exchange does HeartSciences Inc. - Warrant trade on?
HeartSciences Inc. - Warrant trades on the Nasdaq Stock Market
What is the ticker symbol for HeartSciences Inc. - Warrant?
The ticker symbol for HeartSciences Inc. - Warrant is HSCSW on the Nasdaq Stock Market
What is the current price of HeartSciences Inc. - Warrant?
The current price of HeartSciences Inc. - Warrant is 0.0602
When was HeartSciences Inc. - Warrant last traded?
The last trade of HeartSciences Inc. - Warrant was at 10/15/26 02:52 PM ET
What is the market capitalization of HeartSciences Inc. - Warrant?
The market capitalization of HeartSciences Inc. - Warrant is 623.81K
How many shares of HeartSciences Inc. - Warrant are outstanding?
HeartSciences Inc. - Warrant has 624K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap